Digital PCR (dPCR) and Real-time PCR (qPCR) Market is Anticipated to Value Over USD 4.5 Billion by 2026

  • 20 Aug 2019

Digital PCR (dPCR) and Real-time PCR (qPCR) market is expected to value over USD 4.5 billion with a CAGR of 8% during the forecast period 2019-2026.

Digital PCR (dPCR) and Real-time (qPCR) deals with making millions of copies of a particular DNA strand or a gene by sequencing. This method is used for various purposes like research, diagnosis, forensic science, DNA fingerprinting, target-oriented treatment and so on. Such a wide range of applications increase the demand for dPCR and qPCR thus augmenting the digital PCR (dPCR) and real-time (qPCR) market growth.

The research and development sector gets massive funding from the government as well as private organizations for undertaking dPCR and qPCR studies, making it one of the factors influencing digital PCR (dPCR) and real-time (qPCR) market growth.

The development of genetic disorders like down syndrome, Parkinson's disease, grey baby syndrome, turner’s syndrome, etc. are major factors contributing to the rising market demand. Furthermore, the range of diagnostic applications of qPCR and dPCR instruments is responsible for their increasing demand in the market worldwide.

The instruments segment is anticipated to be the dominating factor in the growth of the market amongst the rest. The demand for PCR instruments in end users is high across the globe due to their efficacy, accuracy and precision, and ease of performing diagnostics and tests. Hence this is the key factor for rising growth and CAGR.

Clinical applications are further divided into infectious disease testing, oncology testing, blood screening, etc. Infectious disease testing is the key factor in positively influence market growth due to rising patient population and awareness. Such techniques are preferred more by end users as they provide accurate results and the procedures are less tedious with dPCR and qPCR methods.

Based on the end users the hospitals and diagnostic centres along with research laboratories and academic institutes are the major contributors to market growth and rise in CAGR. The research and academic sectors use qPCR and dPCR technology for further development and study, and hospitals and diagnostic centres are majority end users as they are directly associated with its applications.

North America, Europe, and the Asia Pacific are the dominating regions amongst the rest because of the rising population and the number of disease conditions.  More research and development is carried out and hence demand of qPCR and dPCR market is more in these regions, resulting in large digital PCR (dPCR) and real-time (qPCR) market share.

Competitive Landscape:

The key players in the market are Abbott Laboratories, Agilent Technologies, Inc, Analytik Gena AG, Becton Dickinson and Company, Biomérieux S.A. and so on.

Abbott Laboratories is one of the major companies in this market sector. It provides a range of advanced diagnostic measures like immunoassay analyzers, chromosome enumeration probe, genotyping system, qPCR system, etc. These products are in demand due to their wide applicability, quality, and precision. Hence it is anticipated to have a large share of qPCR and dPCR market across the globe.

FutureWise Key Takeaways:

  • Research and development in dPCR and qPCR technology and pharmaceuticals
  • Focus on new advances in dPCR and qPCR diagnostic instruments
  • Commercialization of qPCR and dPCR methods

Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Segmentation:

By Product and Service:            

  • qPCR and dPCR products and services
    1.  Reagents and consumables
    2.  Instruments
    3.  Software and services

By Application:  

  • qPCR applications and dPCR applications
    1. Forensic applications
    2. Research applications
    3. Clinical applications
      • Infectious disease testing
      • Oncology testing
      • Blood screening
      • Transplant diagnostics
      • Other applications

By End User:

  • dPCR and qPCR end users:
    1. Hospitals and diagnostic centres
    2. Research Laboratories and Academic Institutes
    3. Pharmaceutical and Biotechnology companies
    4. Clinical research organizations
    5. Forensic laboratories

By Region:

  • North America
  • Europe
  • Asia pacific
  • Latin America
  • Middle East and Africa

Objectives of the Study:

  •        To provide with an exhaustive analysis on the digital PCR (dPCR) and Real-time PCR (qPCR) market by product and service, by application, by end user and by region
  •        To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  •        To evaluate and forecast micro-markets and the overall market
  •        To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and Middle East & Africa
  •       To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
  •         Profiling of companies to evaluate their market shares, strategies, financials and core competencies


Get unlimited analyst support and customise this study further to your requirements, contact